-
3-Bromopyruvate and Cetuximab Synergy: Overcoming CRC Resist
2026-06-12
This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab induces autophagy-dependent ferroptosis and apoptosis, overcoming resistance in colorectal cancer cell lines with KRAS or BRAF mutations. The findings illuminate a mechanistically distinct strategy to target refractory metastatic colorectal cancer.
-
Neuromedin S (rat): Technical Use and Workflow Parameters
2026-06-11
Neuromedin S (rat) provides a chemically defined peptide agonist for precise activation of neuromedin U receptor signaling in rat GPCR/G protein studies. It addresses the need for reproducible, validated ligands in controlled research on energy homeostasis, stress response, and circadian rhythm pathways. This product is not suitable for diagnostic or therapeutic applications.
-
MTT: Precision in Cell Viability and Metabolic Activity Assa
2026-06-11
Leverage the reliability of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) for high-sensitivity, reproducible colorimetric cell viability assays. This guide details optimized workflows, real-world applications, and troubleshooting strategies that transform APExBIO’s MTT into a gold-standard solution for quantitative in vitro research.
-
Dual-Mode Tracking: EZ Cap™ Cy5 EGFP mRNA (5-moUTP) in Next-
2026-06-10
Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables simultaneous visualization and functional readout in gene delivery research. This article uniquely integrates machine learning-driven insights and dual fluorescence tracking to guide advanced mRNA delivery assay design.
-
CB-839 (Telaglenastat): Advancing Glutaminolysis Inhibition
2026-06-10
CB-839 (Telaglenastat) provides researchers with a highly selective and reversible tool for dissecting glutamine metabolism in cancer models. This article details applied workflows, troubleshooting strategies, and unique insights from recent epitranscriptomic research, setting a new standard for preclinical cancer metabolism studies.
-
Azithromycin in Translational Research: Mechanism, Models, a
2026-06-09
Explore how Azithromycin, a macrolide antibiotic, empowers translational researchers with precise mechanistic insight and advanced model design. This thought-leadership article bridges rigorous mechanistic understanding to actionable workflow guidance, benchmarking resistance, and translational relevance—offering unique, evidence-driven strategy beyond standard product descriptions.
-
Lambda Protein Phosphatase (RNase-free): Reliable Phosphoryl
2026-06-09
This article delivers a scenario-driven, evidence-based exploration of Lambda Protein Phosphatase (RNase-free), APExBIO SKU K1102, focusing on its pivotal role in enhancing reproducibility and data quality in phosphorylation-dependent assays. By addressing real laboratory challenges, it demonstrates how K1102 streamlines the validation of phospho-specific antibodies and functional analyses in cell viability, proliferation, and circadian biology research.
-
HOXC8 Suppresses Pyroptosis in NSCLC by Regulating Caspase-1
2026-06-08
This study uncovers how HOXC8, a homeobox transcription factor, suppresses pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by downregulating caspase-1 expression. The findings clarify a novel epigenetic mechanism linking tumorigenesis and inflammation, with implications for apoptosis and inflammation research.
-
Honokiol Triggers Paraptosis-Like Death in APL via MAPK/mTOR
2026-06-08
This study demonstrates that honokiol induces paraptosis-like cell death in acute promyelocytic leukemia (APL) cells through activation of the mTOR and MAPK/ERK signaling pathways, independent of apoptosis or classical autophagy. The findings uncover a non-canonical cell death mechanism with therapeutic implications for drug-resistant APL and highlight the utility of pathway-specific inhibitors for mechanistic exploration.
-
Sulfo-Cy5 NHS Ester: Precision Protein Conjugation for Imagi
2026-06-07
Sulfo-Cy5 NHS ester stands out as a hydrophilic, water-soluble fluorescent probe for labeling amine-containing biomolecules under mild, aqueous conditions. Its unique sulfonate-driven solubility, reduced fluorescence quenching, and compatibility with solvent-sensitive proteins make it a powerful tool for quantitative imaging and immune microenvironment analysis.
-
Z-WEHD-FMK: Precision Caspase Inhibition in Inflammation Res
2026-06-06
Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) empowers cell biologists to dissect inflammatory and pyroptotic pathways with unmatched specificity. Its irreversible and cell-permeable action enables robust caspase inhibition for infectious disease and apoptosis assays, setting a new standard for reproducibility and mechanistic insight.
-
HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio
2026-06-05
This study uncovers a novel mechanism in which HOXC8 suppresses caspase-1 expression to prevent pyroptotic cell death in non-small cell lung carcinoma (NSCLC). By clarifying how HOXC8 and HDAC1/2 cooperate to control the caspase signaling pathway, the research provides new insights into inflammation and apoptosis regulation in cancer biology.
-
3X (DYKDDDDK) Peptide: Advanced Epitope Tag for Protein Scie
2026-06-05
The 3X (DYKDDDDK) Peptide is a synthetic trimeric epitope tag that enhances the affinity purification and immunodetection of FLAG-tagged recombinant proteins. Its hydrophilic, triple-repeat sequence supports high sensitivity, minimal structural interference, and compatibility with advanced applications such as metal-dependent ELISA and protein crystallization.
-
Oligomycin A: Powering Mitochondrial Bioenergetics Research
2026-06-04
Oligomycin A, a gold-standard mitochondrial ATP synthase inhibitor from APExBIO, enables precision dissection of cellular metabolism and apoptosis in advanced cancer and metabolic adaptation studies. This article delivers expert-driven workflows, troubleshooting insights, and scenario-based protocol enhancements for robust, reproducible results.
-
HNF4A Hypermethylation by H. pylori as a Driver of Gastric C
2026-06-04
This study elucidates how Helicobacter pylori infection promotes gastric cancer by inducing DNA hypermethylation and silencing the tumor suppressor gene HNF4A. The findings highlight the central role of epigenetic regulation in cancer progression and provide a framework for targeting DNA methylation in translational research.